MAM

MPM Asset Management Portfolio holdings

AUM $43.3M
This Quarter Return
+46.94%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$598M
AUM Growth
+$598M
Cap. Flow
-$41.9M
Cap. Flow %
-7.01%
Top 10 Hldgs %
99.58%
Holding
16
New
1
Increased
–
Reduced
2
Closed
1

Top Buys

1
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
$194K

Top Sells

1
NVRO
NEVRO CORP.
NVRO
$17.7M
2
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
$15.2M
3
EPZM
Epizyme, Inc
EPZM
$9.19M

Sector Composition

1 Healthcare 17.69%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RDUS
1
DELISTED
Radius Health, Inc.
RDUS
$395M 66.06% 5,831,253 – –
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$55.6M 9.3% 1,220,672 – –
EPZM
3
DELISTED
Epizyme, Inc
EPZM
$42.7M 7.15% 1,781,086 -382,733 -18% -$9.19M
PETX
4
DELISTED
Aratana Therapeutics, Inc.
PETX
$32M 5.36% 2,118,845 – –
NVRO
5
DELISTED
NEVRO CORP.
NVRO
$19.2M 3.21% 356,704 -330,000 -48% -$17.7M
TARA icon
6
Protara Therapeutics
TARA
$120M
$17.6M 2.94% 983,381 – –
ALT icon
7
Altimmune
ALT
$338M
$11.4M 1.91% 6,347,614 – –
TRIV
8
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$9.51M 1.59% 1,776,692 – –
VSTM icon
9
Verastem
VSTM
$569M
$6.16M 1.03% 816,683 – –
HSTO
10
DELISTED
Histogen Inc. Common Stock
HSTO
$6.14M 1.03% 1,192,080 – –
SVRA icon
11
Savara
SVRA
$567M
$1.25M 0.21% 2,551,851 – –
ETRM
12
DELISTED
EnteroMedics Inc.
ETRM
$690K 0.12% 1,113,168 – –
SGMO icon
13
Sangamo Therapeutics
SGMO
$157M
$249K 0.04% 22,487 – –
CLCD
14
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$194K 0.03% +21,806 New +$194K
MGNX icon
15
MacroGenics
MGNX
$112M
$120K 0.02% 3,168 – –
EIGR
16
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– – -800,542 Closed -$15.2M